| Stage | ESAB | % of rev | ULS | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $808M | 100.00% | $816M | 100.00% | ULS ×1.01 |
| Gross profit | $307M | 38.04% | $417M | 51.10% | ULS +13.1pp |
| Operating income | $79M | 9.75% | $150M | 18.38% | ULS +8.6pp |
| Pre-tax income | $48M | 5.96% | $338M | 41.42% | ULS +35.5pp |
| Net income | $34M | 4.21% | $254M | 31.13% | ULS +26.9pp |
| Stage | ESAB | ULS | Gap · A − B |
|---|---|---|---|
| Revenue | $808M100.00% | $816M100.00% | ULS ×1.01 |
| Gross profit | 38.04%$307M | 51.10%$417M | ULS +13.1pp |
| Operating income | 9.75%$79M | 18.38%$150M | ULS +8.6pp |
| Pre-tax income | 5.96%$48M | 41.42%$338M | ULS +35.5pp |
| Net income |
| 4.21%$34M |
| 31.13%$254M |
| ULS +26.9pp |
No shared counterparties.